Non-hodgkin lymphoma Archives

$EC Approves Roche’s Bispecific Antibody Columvi for Relapsed or Refractory Diffuse Large B-Cell Lymphoma$

News & Features

EC Approves Roche’s Bispecific Antibody Columvi for Relapsed or Refractory Diffuse Large B-Cell Lymphoma

Chris Anderson -

July 11, 2023

Low grade ductal carcinoma with positive estrogen receptor

News & Features

Remote Nutrition Counseling for Lymphoma Patients with Fatigue Shows Promise

Malorye Branca -

February 15, 2023

Cancer associated fibroblasts layer on tumor microenvironment

News & Features

First Reversible BTK Inhibitor, Jaypirca, Approved for Mantle Cell Lymphoma

Malorye Branca -

January 31, 2023

Hospitalized cancer patient undergoing chemotherapy.

News & Features

Potential New Treatment Improving Chemotherapy Efficacy and Reducing Metastasis Discovered

Alisa Kirkin -

November 8, 2022

Burkitt's lymphoma cells, is a cancer of the lymphatic system

News & Features

AbbVie and Genmab’s Epcoritamab for Large B-Cell Lymphoma Advances

Malorye Branca -

April 15, 2022

Gloved hand holding COVID-19 vaccine in syringe on a background of SARS-CoV-2 particles to represent preventive effect against diabetes and other health issues

Coronavirus

Most Metastatic Cancer Patients Produce Antibodies After COVID mRNA Vaccination

Chris Anderson -

March 16, 2022

DNA sequence with colored letters on black background containing mutation

Molecular Dx

Genomic Alterations Identified in Cutaneous T-Cell Lymphoma Could Provide Path to New Therapies

Chris Anderson -

March 1, 2022

News & Features

FDA Puts Five Trials of Gilead Cancer Candidate Magrolimab on Partial Hold

Alex Philippidis -

January 26, 2022

News & Features

CAR T-Cell Therapy for High-Risk Lymphoma Makes Case as Standard-of-Care Treatment

Chris Anderson -

January 5, 2022

T-cells attacking cancer cell illustration of microscopic photos

News & Features

Two-Step Process Allows CAR-T Therapy to Better Target Solid Tumors

Christina Jackson -

March 23, 2021

12 Page 1 of 2

AbbVie Buys ImmunoGen for $10.1B to Speed Entry into Ovarian Cancer…

Biological Robots Show Healing Potential

ACC and AHA Issue New Guideline for Preventing and Optimally Managing…

Slow Brain Waves: A Natural Shield against Epileptic Activity

Nasal Swab Test Separates High- from Low-Risk Lung Cancer Polyps

Non-hodgkin lymphoma

EC Approves Roche’s Bispecific Antibody Columvi for Relapsed or Refractory Diffuse Large B-Cell Lymphoma

Remote Nutrition Counseling for Lymphoma Patients with Fatigue Shows Promise

First Reversible BTK Inhibitor, Jaypirca, Approved for Mantle Cell Lymphoma

Potential New Treatment Improving Chemotherapy Efficacy and Reducing Metastasis Discovered

AbbVie and Genmab’s Epcoritamab for Large B-Cell Lymphoma Advances

Most Metastatic Cancer Patients Produce Antibodies After COVID mRNA Vaccination

Genomic Alterations Identified in Cutaneous T-Cell Lymphoma Could Provide Path to New Therapies

FDA Puts Five Trials of Gilead Cancer Candidate Magrolimab on Partial Hold

CAR T-Cell Therapy for High-Risk Lymphoma Makes Case as Standard-of-Care Treatment

Two-Step Process Allows CAR-T Therapy to Better Target Solid Tumors

Related Content

AbbVie Buys ImmunoGen for $10.1B to Speed Entry into Ovarian Cancer and Other Solid Tumors

Nutrient Found in Red Meat and Dairy Products Could Boost Cancer Therapies

Personalis Lands Tempus as Partner to Co-Commercialize Its MRD Test in Lung and Breast Cancer

Scientists Unveil Technique for Pinpointing Autoimmune Disease Causes and Treatments